PetIQ logo
PetIQ PETQ

Annual report 2023
added 02-29-2024

report update icon

PetIQ Market Cap 2011-2025 | PETQ

As of December 15, 2025 PetIQ has a market cap of $ 400 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap PetIQ

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
396 M 397 M 641 M 854 K 696 M 503 M 323 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
696 M 854 K 422 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Drug manufacturers industry

Issuer Market Cap Price % 24h Market Cap Country
Canopy Growth Corporation Canopy Growth Corporation
CGC
142 M $ 1.68 -3.44 % $ 181 M canadaCanada
Alimera Sciences Alimera Sciences
ALIM
101 M - - $ 142 M usaUSA
Assertio Holdings Assertio Holdings
ASRT
66.1 M $ 0.74 -3.53 % $ 52.6 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
325 M - - $ 754 M usaUSA
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
22.2 M - 7.5 % $ 6.35 M usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
18 M - 0.86 % $ 117 M usaUSA
Cronos Group Cronos Group
CRON
3.63 B $ 3.05 -6.88 % $ 1.61 B canadaCanada
Agile Therapeutics Agile Therapeutics
AGRX
1.29 M - 10.11 % $ 58.2 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
915 M $ 5.1 -5.59 % $ 86.3 M canadaCanada
Catalent Catalent
CTLT
10.9 B - - $ 11.5 B usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
966 M - -0.1 % $ 2.03 B schwedenSchweden
HEXO Corp. HEXO Corp.
HEXO
89 M - 2.45 % $ 38.1 M canadaCanada
DURECT Corporation DURECT Corporation
DRRX
31.8 M - - $ 50.1 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
415 M $ 4.76 -1.14 % $ 627 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
340 M - -39.89 % $ 27.7 M usaUSA
Endo International plc Endo International plc
ENDP
68.2 M - - $ 28.9 M irlandaIrlanda
Pacira BioSciences Pacira BioSciences
PCRX
1.18 B $ 26.64 1.33 % $ 1.23 B usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
139 M $ 12.27 7.44 % $ 628 M usaUSA
Evoke Pharma Evoke Pharma
EVOK
2.24 M $ 10.97 0.14 % $ 36.7 M usaUSA
Athenex Athenex
ATNX
11.4 M - -23.39 % $ 1.76 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
35.5 M $ 0.88 -5.2 % $ 20.5 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
717 M $ 21.43 0.3 % $ 2.04 B franceFrance
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
3.66 M $ 3.52 -2.07 % $ 4.37 M usaUSA
Evolus Evolus
EOLS
887 M $ 7.14 1.42 % $ 443 M usaUSA
Harrow Health Harrow Health
HROW
347 M $ 46.39 -1.43 % $ 1.51 B usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
4.54 M $ 1.53 -1.92 % $ 26.7 M chinaChina
Bausch Health Companies Bausch Health Companies
BHC
3.38 B $ 6.87 -0.79 % $ 2.51 B canadaCanada
Veru Veru
VERU
108 M $ 2.39 -1.24 % $ 322 M usaUSA
Lannett Company Lannett Company
LCI
39.4 M - 1.15 % $ 7.11 M usaUSA
OrganiGram Holdings OrganiGram Holdings
OGI
382 M $ 1.81 -5.99 % $ 402 M canadaCanada
cbdMD cbdMD
YCBD
1.68 M $ 1.18 -3.28 % $ 5.09 M usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
88.6 M $ 3.04 20.16 % $ 42.7 M usaUSA
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
1.72 M - - $ 193 M canadaCanada
Solid Biosciences Solid Biosciences
SLDB
226 M $ 5.77 -1.79 % $ 236 M usaUSA
Relmada Therapeutics Relmada Therapeutics
RLMD
162 M $ 4.34 6.9 % $ 131 M usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
82.8 M - - $ 33.6 M usaUSA
Perrigo Company plc Perrigo Company plc
PRGO
3.96 B $ 12.77 -2.85 % $ 1.75 B usaUSA
ProPhase Labs ProPhase Labs
PRPH
131 M $ 0.12 0.87 % $ 1.9 M usaUSA
Radius Health Radius Health
RDUS
378 M - - $ 1.42 B usaUSA
Recro Pharma Recro Pharma
REPH
133 M - -4.76 % $ 65.3 M usaUSA
Sundial Growers Sundial Growers
SNDL
889 K $ 1.96 -11.31 % $ 3.37 M canadaCanada
OptiNose OptiNose
OPTN
192 M - - $ 1.08 B usaUSA
PLx Pharma PLx Pharma
PLXP
118 M - -27.8 % $ 2.56 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
70.3 M $ 0.64 -0.91 % $ 30.6 M usaUSA
Tricida Tricida
TCDA
359 M - - $ 3.25 M usaUSA
Tilray Tilray
TLRY
1.19 B $ 11.19 -7.9 % $ 6.92 B canadaCanada
TherapeuticsMD TherapeuticsMD
TXMD
23.9 M $ 1.7 -2.86 % $ 17.7 M usaUSA
Zomedica Corp. Zomedica Corp.
ZOM
137 M - -0.21 % $ 98 M usaUSA
Viatris Viatris
VTRS
13.6 B $ 11.65 - $ 14.1 B usaUSA